Heme oxygenase-1 impairs hormone- dependent breast cancer cell survival through its enzyme activity
; Schweitzer, Karen
; Mascaró, Marilina
; Rebassa, Martin Enrique ; Gómez, Florencia Magali ; Colo, Georgina Pamela
; Fermento, María Eugenia
; Ferronato, María Julia
; Alonso, Eliana Noelia
; Curino, Alejandro Carlos
; Facchinetti, Maria Marta 
Otros responsables
Fecha
2023
Editorial
Fundación Revista Medicina
Revista
Título del libro
Nombre del evento
LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento
2023-11-15
Institución organizadora
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Biología
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Sociedad Argentina de Biología
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
ISSN
0025-7680
eISSN
1669-9106
ISBN
Idioma
Inglés
Tipo del evento
Reunión
Clasificación temática
Palabras clave
Resumen
We have previously reported that induction of Heme Oxygenase-1 (HO-1), an enzyme that catalyzes heme degradation and releases iron, impairs breast cancer (BC) cell survival in both murine hor- mone-independent (LM3) and human triple-negative (MDA-MB-231) BC cell lines, most likely through ferroptosis induction. In this study, we aimed to evaluate the HO-1 modulation on hormone-dependent BC cell survival and to assess the involvement of HO-1 enzyme activity. To this end, we modulated HO-1 in T47D cell line by phar- macological induction (hemin, 36h) and by stable overexpression of wild-type HO1 (WT-HO1) or enzymatically inactive-H25AHO-1 (H25A). We studied cell viability (crystal violet), iron storage (Prus- sian blue), ROS levels (DFCA), lipid peroxidation (MDA accumula- tion) and the expression of ZIP14 iron importer (immunocytochem- istry). We also carried out correlation studies between HO-1 mRNA levels and L-ferritin in BC subtypes (bioinformatics analysis). We found that hemin treatment and WT-HO1 overexpression decreased T47D cell viability (p<0.01 and p<0.05 respectively) and increased iron storage (p<0.05 in both), ROS levels (p<0.01 and p<0.05 re- spectively), MDA accumulation (p<0.01 in both) and ZIP14 expres- sion. The treatment with an antioxidant (N-Acetylcysteine) and an iron chelator (deferoxamine) reversed the reduction of BC cell via- bility induced by hemin and by WT-HO-1 overexpression (p<0.001 and p<0.05 respectively). On the contrary, H25A cell viability was higher and the ROS levels and MDA accumulation were lower than in WT-HO1 cells (p<0.05). Bioinformatics studies confirmed a posi- tive correlation between HO-1 mRNA and L-ferritin in BC subtypes (ER+, ER-, Basal-like, Normal-like, Luminal and HER2 enriched). In conclusion, HO-1 induction impairs cell viability in a hormone-de- pendent BC subtype through an increase in free iron accumulation, ROS production and lipid peroxidation, being the enzymatic activity of HO-1 necessary for its effect on cell viability.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
